Health
Novel Approach for Intravenous Cancer Immunotherapy – Genetic Engineering & Biotechnology News
Researchers report they have developed nanoparticles to deliver STING agonists and metal ions for intravenous cancer immunotherapy….
Researchers at the University of Michigan (U-M) School of Pharmacy and the Rogel Cancer Center took a different approach to boosting the STING pathway. The team observed that adding the nutritional metal ion manganese to STING agonists boosted STING’s tumor-fighting…
Continue Reading
-
Business19 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General19 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General20 hours agoTroops critically injured in Washington shooting named as FBI launch terror probe
-
General18 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting